Leading with its benchmark facilities serving the CDO, CMO, and CDMO industries, we offer a comprehensive array of dedicated services under our contract manufacturing model, which are now available for finished dosage forms.

Our Formulations Capability:

• Soft Gel Capsules - Unit 10 Bavla, India - over 2780 m2 of total built-in area (Units 10 A & 10 B)

Soft Gel Capsules:

Dishman Carbogen Amcis Ltd has largely indulged in developing sophisticated infrastructure, enabling the production of various novel dosage formulations in soft gelatin capsules, such as Therapeutic and OTC drugs.

• Pilot soft gel facility - 500 m2 with 30 million capsules per annum capacity
• Commercial Soft gel facility - 2320 m2 with 300 million capsules per annum capacity

• Current accreditations: 
• WHO-CDSCO (India - 2024)
• GMP certificate from Ministry of Health Pharmacy & Poisons Board (PPB), Republic of Kenya (2023)
• Supreme Board of Drugs & Medical Appliances (SBDMA), Republic of Yemen (2024)

The plant is designed to meet the highest regulatory quality standards by stringent NRAs. We comply with stringent NRAs (USFDA, UK-MHRA, EU GMP).